Next Article in Journal
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS
Next Article in Special Issue
Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis
Previous Article in Journal
Targeting the KRAS Oncogene for Patients with Metastatic Colorectal Cancer
Previous Article in Special Issue
Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals
 
 
Review

Article Versions Notes

Cancers 2025, 17(9), 1513; https://doi.org/10.3390/cancers17091513
Action Date Notes Link
article html file updated 30 April 2025 08:54 CEST Original file -
article xml file uploaded 30 April 2025 08:55 CEST Original file -
article xml uploaded. 30 April 2025 08:55 CEST Update https://www.mdpi.com/2072-6694/17/9/1513/xml
article pdf uploaded. 30 April 2025 08:55 CEST Version of Record https://www.mdpi.com/2072-6694/17/9/1513/pdf
article supplementary file uploaded. 30 April 2025 08:55 CEST - https://www.mdpi.com/2072-6694/17/9/1513#supplementary
article html file updated 25 June 2025 02:30 CEST Update https://www.mdpi.com/2072-6694/17/9/1513/html
Back to TopTop